Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Olympus to Beef Up Biomaterials, Tissue Engineering Business
October 4, 2004
- MediciNova to Step Forward in Global Drug Development, Commercialization
October 4, 2004
- Iryo Proverbs Reveal Japanese Spirit (23)
October 4, 2004
- Booklet on MRs' Roles to Be Thoroughly Revised
October 4, 2004
- Pip-Tokyo, Alfresa to Set Up SPD/Medical Materials JV House
October 4, 2004
- So-net M3 Sets Up Physicians' Job Change Site for Drug Houses
October 4, 2004
- DIAGNOSTIC NEWS IN BRIEF
October 4, 2004
- REGULATORY NEWS IN BRIEF
October 4, 2004
- WORLD NEWS IN BRIEF
October 4, 2004
- BUSINESS NEWS IN BRIEF
October 4, 2004
- IITs Involve Insurance-related Problems
October 4, 2004
- NEW PRODUCTS
October 4, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
October 4, 2004
- CORPORATE ROUNDUP NEWS IN BRIEF
October 4, 2004
- GVP, GQP GLs Promulgated
October 4, 2004
- Korosho, Monkasho Hold Hearings on Promotion of Clinical Trials
October 4, 2004
- Only 6.9% of Medical Bills Processed Electronically
October 4, 2004
- CDFS Task Force to Draft New GL on Use of Blood Products
September 27, 2004
- Strategic Health Care Industry Reform Conference
September 27, 2004
- REGULATORY NEWS IN BRIEF
September 27, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…